Good morning, everyone, and how are you today? We are fine, thank you, and hope you are, too. Of course, we have much on our mind as we navigate the middle of the week - meetings, deadlines, documents to read, calls to make. You know the drill. So why dither? Please join us for a cup of delicious stimulation - Golden French Toast is on the menu - and dig in for another busy day. To help you along, here are some invigorating tidbits. Have a great one and stay in touch...
Roche Warns Of Counterfeit Avastin In The US (Associated Press)
J&J Sold Hip Implants Overseas After FDA Rejection (New York Times)
Glaxo Uses Mediation To Settle 25,000 Avandia Cases (Bloomberg News)
Hospira Resumes Production At North Carolina Plant (Reuters)
Hepatitis C Combinations And The Race For Acquisitions (Bloomberg News)
Antibiotics Do Not Work Against Most Sinus Infections (Reuters)
Drug Shortage Bill Attached To Transportation Legislation (Reuters)
China To Expand Drug List, And More Price Cuts Seen (Bloomberg News)
Lonza Denies South African API Plant Deal Is Done (Outsourcing Pharma)
FDA OKs Testosterone Gel From Teva And BioSante (Bloomberg News)
Judge Sets First Hearing For Actos Lawsuits (Associated Press)
Karo Bio Ends Spin Off Plans (Pharma Times)
J&J Tries To Ease EU Concerns About Synthes Acquistion (Reuters)
EDITOR'S NOTE: Please check this post for updates throughout the morning
Coffee pix thx to chichcacha flickr creative commons